Senthil Sundaram - May 31, 2023 Form 4 Insider Report for Terns Pharmaceuticals, Inc. (TERN)

Role
Chief Executive Officer, Director
Signature
/s/ Bryan Yoon, as Attorney-in-Fact for Senthil Sundaram
Stock symbol
TERN
Transactions as of
May 31, 2023
Transactions value $
$2,977
Form type
4
Date filed
6/2/2023, 05:03 PM
Previous filing
Feb 3, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TERN Common Stock Purchase $2.98K +2.11K +27.56% $1.41* 9.77K May 31, 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes the purchase of 2,111 shares under the Terns Employee Stock Purchase Plan on May 31, 2023.

Remarks:

Voluntary reporting of ESPP purchase